December 14, 2023
U.S. Neurologists Eagerly Await Promising Oral BTKis in MS Treatment Pipeline, Though Recent Trial Readouts Might Hamper Initial Excitement
- /
- /
- /
Efficacy and safety of pipeline multiple sclerosis assets viewed as increasingly important characteristics, according to Spherix Global Insights. [Exton PA, December 13,…
